The essential role of Atrogin-1 and MuRF-1 in maintaining skeletal muscle mass [11], [12], [13] makes these two muscle-specific ubiquitin ligases attractive targets for pharmacological intervention in insulin resistance and type 2 diabetes. Here, FBXO32 is linked to type 2 diabetes mellitus.